Category Archives: Opportunities

Opportunity Alert: Four NIH SBIR Programs Now Open for Applications

Posted on by

NCI PREVENT Cancer Program

The NCI PREVENT Cancer Program provides resources to move novel cancer-preventive chemical or biological agents and biomarkers towards clinical testing. Through a partnership with NCI, promising chemopreventive agents will be optimized and tested with the goals of filing an Investigational New Drug application with the U.S. FDA and entering the agent into clinical testing. Click here to learn more. The next deadline to apply is October 7, 2013.

NCI NExT Program

The NCI Experimental Therapeutics (NExT) Program consolidates NCI’s anticancer drug discovery and development resources in support of a goal-driven therapeutics pipeline. NCI partners with researchers from industry or academia to facilitate the milestone-driven progression of new anticancer drugs and imaging agents towards clinical evaluation and registration. Click here to learn more. The next deadline to apply is October 15, 2013.

NCI CADP

The NCI Clinical Assay Development Program (CADP) provides resources for clinical assay validation to assist with the development of assays that may predict therapy response or prognostic behavior of a diagnosed cancer, primarily for use in clinical trials. Click here to learn more. The next deadline to apply is October 15, 2013.

NCATS Therapeutics for Rare and Neglected Disease (TRND) Program

The National Center for Advancing Translational Sciences (NCATS) is pleased to announce an open opportunity to submit proposals to collaborate with the Therapeutics for Rare and Neglected Diseases (TRND) program.

The TRND program supports preclinical and early clinical development of new drugs for rare and neglected tropical diseases by establishing collaborative partnerships with external researchers. Intended candidates for collaboration will be researchers who have promising leads and disease/target knowledge, but who lack the expertise or resources to fully develop these projects into clinical stage programs attractive to biopharmaceutical or other suitable organizations. TRND seeks to partner with academic laboratories, not-for-profit organizations, and for-profit companies. Foreign organizations are eligible to apply. TRND provides significant in-kind research support, but no direct external funding is available.Interested applicants may visit TRND on the web to learn more about the program, and can refer to the current NIH Guide Notice for more information.

Interested applicants must contact the TRND Solicitation Coordinator by email (TRND@mail.nih.gov) to initiate a pre-screening / Letter of Intent (LOI) process. Applications are made through the online proposal system, proposalCENTRAL (https://proposalcentral.altum.com/).

LOIs must be completed no later than September 16, 2013. Final applications are due by September 30, 2013.

12th Annual BIO Investor Forum in October

Posted on by

 

Announcing the 12th Annual BIO Investor Forum

The Biotechnology Industry Organization (BIO) is pleased to announce its advisory committee for the 12th Annual BIO Investor Forum, an international biotech investor conference focused on investment strategies for early stage and established private companies as well as emerging public companies. The event will take place October 8-9, 2013 at the Palace Hotel in San Francisco, Calif.

This esteemed group will help set the agenda and program for this year’s event which will assemble public and venture-stage growth companies, as well as top public and private equity investors, to explore investment trends and opportunities in life sciences.

Advisory Committee members include:

  • Srini Akkaraju, MD, PhD, General Partner, Sofinnova Venture
  • Katrine Bosley, (former) CEO, Avila Therapeutics
  • Ashley Dombkowski, CBO, 23andMe
  • Todd Foley, Managing Director, MPM Capital
  • Gail Maderis, President & CEO, BayBio
  • Janis Naeve, PhD, Managing Director, Amgen Ventures
  • Bryan Roberts, PhD, Partner, Venrock
  • Eugene Rozelman, Managing Director, Canaccord Genuity
  • Francesco De Rubertis, PhD, Partner, Index Ventures
  • Geeta Vemuri, PhD, VP, Head, Baxter Ventures
  • Barbara Yanni, Vice President & Chief Licensing Officer, Merck
  • Krishna Yeshwant, Partner, Google Ventures

In addition to panel discussions led by clinical thought leaders focusing on hot therapeutic areas, the conference features business roundtables focused on financing, investment and the latest M&A trends. BIO One-on-One Partnering™ will also provide an opportunity to arrange meetings between investors; companies; and industry business development, licensing and therapeutic franchise heads.

 

The BIO Investor Forum has become the ideal venue for investors and business development leaders to discuss financial and strategic business issues affecting investment in biotech companies, and explore potential partnerships and business collaborations to fuel research and development for promising innovation. Last year’s conference scheduled over 650 meetings. Nearly 80% of all requests were between biotech companies and investors.  Furthermore, the event hosted nearly 110 late-stage private and emerging public company presentations.

The meeting attracts healthcare venture capital and public market investors and research analysts as well as business development executives from leading global pharmaceutical and biotechnology companies.

For more information, please go to bio.org/investorforum.

BIO Investor Forum Features

  • BIO 1×1 Meetings
  • Plenary Sessions and Workshops
  • Company Presentations
  • Networking Opportunities

Venue Information

The Palace Hotel

2 New Montgomery Street
San Francisco, CA 94105

 

What will the BIO Investor Forum mean to your company?Contact Us

 

Customer Service:

1.866.356.5155 (U.S.) or
+1.202.962.6666 (International)
biopartnering@bio.org.

Sponsorship Opportunities:

John Sloan, Managing Director,
External Relations & Development, BIO
jsloan@bio.org.

 

Ready Set Launch Trains HS Student Entrepreneurs at CEI

Posted on by
Ready Set Launch, June 17-21

Ready Set Launch!

The Center for Entrepreneurial Innovation is excited to host “Ready Set Launch!” June 17-21, a week-long entrepreneurial experience for high school sophomores, juniors and seniors.
Goals of the Event
Gain understanding of entrepreneurship as a viable career option and learn about resources in their community
Generate business ideas to create an atmosphere of fun
Meet and learn from successful entrepreneurs
Learn to work and cooperate in groups
Develop critical thinking and life skills
Develop leadership abilities and skills
Identify and evaluate entrepreneurial opportunities in Northern Arizona
What Students Will Gain
Make new friends
Opportunity to win awards for Best Business Plan and Presentation
Experiential/hands on learning
Learn about starting and running a business
When
June 17 through June 21, 2013
8:30am to 5:00pm (Mon-Thurs)
9:00am to 1:00pm (Fri)
How to Apply
Please download the application and reference form here and return by June 6th, 2013 to:
The Center for Entrepreneurial Innovation
275 N. GateWay Drive
Phoenix, Arizona 85034
Attn: Greg Bullock
– – OR – –
*Participation will be limited to 25 students, and all applicants will be notified by June 11, 2013.
Ready Set Launch!, June 17-21

Opportunity Alert: BioAccel Solutions Challenge Announced

Posted on by

BioAccel will identify up to 5 health care needs based on input from health care professionals, industry and the consumer. Up to 3 will be in the medical device space and up to 2 will be in the medical diagnostics space.  Winners will have a chance to receive a minimum of $50,000 of proof-of-concept funds from BioAccel if they can obtain a matching $50,000 from investors.Continue reading→